Fluoguide AS Cash Flow Conversion Efficiency

Latest as of September 2025: 4.485x

Fluoguide AS cash flow conversion efficiency. Based on the latest financial reports, Fluoguide AS (FLUO) has a cash flow conversion efficiency ratio of 4.485x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.97 Million ≈ $-1.18 Million USD) by net assets (Skr-2.44 Million ≈ $-263.12K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Fluoguide AS (2018–2024)

Cash flow conversion efficiency of Fluoguide AS from 2018 to 2024. This chart illustrates how Fluoguide AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Fluoguide AS stock price today for real-time trading data and today's change.

Fluoguide AS Cash Flow Conversion Ratio Explained

Fluoguide AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Fluoguide AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fluoguide AS ranked by their cash flow conversion efficiency. Also see how much is Fluoguide AS worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Yojee Ltd
AU:YOJ
-0.167x
Seoul Auction Co. Ltd
KQ:063170
0.048x
Globaltec Formation Bhd
KLSE:5220
0.061x
ATrack Technology
TWO:6465
0.175x
Pliant Therapeutics Inc
NASDAQ:PLRX
-0.087x
Averbuch Formica Center Ltd
TA:AVER
0.047x
Santova Ltd
JSE:SNV
0.078x
Accelerate Property Fund Ltd
JSE:APF
0.025x

Annual Cash Flow Conversion Efficiency for Fluoguide AS (2018–2024)

The table below shows the annual cash flow conversion efficiency of Fluoguide AS from 2018 to 2024. Review FLUO cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr23.07 Million
≈ $2.48 Million
Skr-29.15 Million
≈ $-3.14 Million
-1.264x +49.46%
2023-12-31 Skr12.72 Million
≈ $1.37 Million
Skr-31.81 Million
≈ $-3.42 Million
-2.501x -112.36%
2022-12-31 Skr31.97 Million
≈ $3.44 Million
Skr-37.65 Million
≈ $-4.05 Million
-1.178x -202.57%
2021-12-31 Skr38.70 Million
≈ $4.16 Million
Skr-15.06 Million
≈ $-1.62 Million
-0.389x +80.60%
2020-12-31 Skr4.41 Million
≈ $474.69K
Skr-8.85 Million
≈ $-952.08K
-2.006x +13.68%
2019-12-31 Skr4.54 Million
≈ $488.79K
Skr-10.55 Million
≈ $-1.14 Million
-2.323x -1390.74%
2018-12-31 Skr7.00K
≈ $753.31
Skr-1.09K
≈ $-117.41
-0.156x --

About Fluoguide AS

ST:FLUO Sweden Biotechnology
Market Cap
$53.31 Million
Skr495.38 Million SEK
Market Cap Rank
#21467 Global
#398 in Sweden
Share Price
Skr30.30
Change (1 day)
-0.66%
52-Week Range
Skr30.00 - Skr46.70
All Time High
Skr177.94
About

FluoGuide A/S, a clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company has a collaboration agreement with ZEISS Medical T… Read more